Cognitive status in patients with multiple sclerosis in Lanzarote.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27418825)

Published in Neuropsychiatr Dis Treat on June 30, 2016

Authors

María Yaiza Pérez-Martín1, Pablo Eguia-Del Río2, Montserrat González-Platas1, Alejandro Jiménez-Sosa3

Author Affiliations

1: Service of Neurology, Complejo Hospitalario Universitario de Canarias, La Laguna.
2: Service of Neurology, Doctor José Molina Orosa Hospital, Arrecife, Lanzarote.
3: Unit of Research, Complejo Hospitalario Universitario de Canarias, La Laguna, Spain.

Articles cited by this

The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32

Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology (1974) 7.34

Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills (1977) 6.58

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology (1991) 5.69

Cognitive impairment in multiple sclerosis. Lancet Neurol (2008) 3.77

Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry (2005) 2.35

Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol (2003) 1.79

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol (2001) 1.64

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain (2010) 1.60

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler (2003) 1.49

Social cognition and Theory of Mind in patients with relapsing-remitting multiple sclerosis. Eur J Neurol (2009) 1.48

Prevalence of multiple sclerosis in Lanzarote (Canary Islands) Neurology (1989) 1.45

Cognition in multiple sclerosis. Curr Opin Neurol (2011) 1.41

Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol (1990) 1.24

Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler (2010) 1.22

Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology (2000) 1.19

Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology (2004) 1.18

Neuropsychology of multiple sclerosis--an overview. J Neurol (2006) 1.01

Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature. Int J Rehabil Res (2013) 0.99

Clinical and psychometrical study of a patient with memory disturbances. Int J Neurol (1968) 0.93

Cognitive impairment differs between primary progressive and relapsing-remitting MS. Neurology (2013) 0.93

Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.93

Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci (2010) 0.91

Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's disease. Neural Plast (2012) 0.91

Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis. PLoS One (2013) 0.91

Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment. Mult Scler Int (2014) 0.87

Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain. Neuroepidemiology (2004) 0.87

"Keep up the good work"! A case study of the effects of a specific cognitive training in Alzheimer's disease. Neurocase (2012) 0.85

Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis. Arch Clin Neuropsychol (2013) 0.83

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. JAMA Neurol (2015) 0.82

Does fatigue complaint reflect memory impairment in multiple sclerosis? Mult Scler Int (2014) 0.80

Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS. J Neuropsychiatry Clin Neurosci (2015) 0.79

Epidemiology of multiple sclerosis in the Canary Islands (Spain): a study on the island of La Palma. J Neurol (2002) 0.79

Neurodegeneration and cognition in Parkinson's disease: a review. Eur Rev Med Pharmacol Sci (2015) 0.79

Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country. J Clin Exp Neuropsychol (2011) 0.78

[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs]. Rev Med Chil (2012) 0.78

Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter? Arch Neurol (1990) 0.78

Cognitive function in older adults with major depression: Effects of mineralocorticoid receptor stimulation. J Psychiatr Res (2015) 0.76

Articles by these authors

Efficacy of a short cognitive training program in patients with multiple sclerosis. Neuropsychiatr Dis Treat (2017) 0.75